These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22252710)
21. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD. Tohda C; Nakada R; Urano T; Okonogi A; Kuboyama T Int J Neurosci; 2011 Dec; 121(12):641-8. PubMed ID: 21770858 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404 [TBL] [Abstract][Full Text] [Related]
23. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related]
24. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094 [TBL] [Abstract][Full Text] [Related]
25. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Ricobaraza A; Cuadrado-Tejedor M; Pérez-Mediavilla A; Frechilla D; Del Río J; García-Osta A Neuropsychopharmacology; 2009 Jun; 34(7):1721-32. PubMed ID: 19145227 [TBL] [Abstract][Full Text] [Related]
26. The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer's disease and vascular dementia. Min D; Guo F; Zhu S; Xu X; Mao X; Cao Y; Lv X; Gao Q; Wang L; Chen T; Shaw C; Hao L; Cai J Neurosci Lett; 2013 Mar; 538():60-5. PubMed ID: 23403102 [TBL] [Abstract][Full Text] [Related]
27. 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease. Zhang Z; Liu X; Schroeder JP; Chan CB; Song M; Yu SP; Weinshenker D; Ye K Neuropsychopharmacology; 2014 Feb; 39(3):638-50. PubMed ID: 24022672 [TBL] [Abstract][Full Text] [Related]
28. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease. Ding Y; Qiao A; Fan GH Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617 [TBL] [Abstract][Full Text] [Related]
29. [Protective effect of adeno-associated viral vector-mediated expression of human brain-derived neurotrophic factor in rat neurons against beta-amyloid-induced Alzheimer's disease in vitro]. Liu ZH; Ma DL; Jin H; Ma YB; Hu HT Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1388-93. PubMed ID: 17062333 [TBL] [Abstract][Full Text] [Related]
30. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease. Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074 [TBL] [Abstract][Full Text] [Related]
31. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077 [TBL] [Abstract][Full Text] [Related]
32. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Choi Y; Kim HS; Shin KY; Kim EM; Kim M; Kim HS; Park CH; Jeong YH; Yoo J; Lee JP; Chang KA; Kim S; Suh YH Neuropsychopharmacology; 2007 Nov; 32(11):2393-404. PubMed ID: 17406652 [TBL] [Abstract][Full Text] [Related]
33. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA. Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105 [TBL] [Abstract][Full Text] [Related]
34. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
35. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
36. Smilagenin attenuates beta amyloid (25-35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor. Zhang R; Wang Z; Howson PA; Xia Z; Zhou S; Wu E; Xia Z; Hu Y Neuroscience; 2012 May; 210():275-85. PubMed ID: 22441042 [TBL] [Abstract][Full Text] [Related]
37. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease. Fu AL; Zhou CY; Chen X Neuropharmacology; 2010; 58(4-5):722-9. PubMed ID: 20045708 [TBL] [Abstract][Full Text] [Related]
38. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease. Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930 [TBL] [Abstract][Full Text] [Related]
39. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681 [TBL] [Abstract][Full Text] [Related]